BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20054324)

  • 1. A case of hidradenitis suppurativa refractory to anti-TNFalpha therapy in a patient with Crohn's disease.
    Koilakou S; Karapiperis D; Tzathas C
    Am J Gastroenterol; 2010 Jan; 105(1):231-2. PubMed ID: 20054324
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient.
    Katsanos KH; Christodoulou DK; Tsianos EV
    Am J Gastroenterol; 2002 Aug; 97(8):2155-6. PubMed ID: 12190206
    [No Abstract]   [Full Text] [Related]  

  • 4. Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to anti-TNF therapy.
    Roussomoustakaki M; Dimoulios P; Chatzicostas C; Kritikos HD; Romanos J; Panayiotides JG; Kouroumalis EA
    J Gastroenterol; 2003; 38(10):1000-4. PubMed ID: 14614610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association and management of Crohn's disease plus hidradenitis suppurativa.
    dos Santos CH; Netto PO; Kawaguchi KY; Parreira Alves JA; de Alencar Souza VP; Reverdito S
    Inflamm Bowel Dis; 2012 Apr; 18(4):E801-2. PubMed ID: 21993924
    [No Abstract]   [Full Text] [Related]  

  • 6. Hidradenitis suppurativa and Crohn's disease: two cases that support an association.
    Yazdanyar S; Miller IM; Jemec GB
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa.
    Brunasso AM; Massone C
    Eur J Dermatol; 2010; 20(5):644-6. PubMed ID: 20615818
    [No Abstract]   [Full Text] [Related]  

  • 8. Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?
    Martina E; Campanati A; Giuliodori K; Offidani A
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):21-23. PubMed ID: 28352932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's disease and hidradenitis suppurativa. An uncommon association that responds to infliximab.
    Blazquez I; Gonzalez-Lama Y; Roustan G
    J Crohns Colitis; 2013 Dec; 7(12):e717-8. PubMed ID: 24080248
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
    Moschella SL
    Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
    Diamantova D; Lomickova I; Cetkovska P
    Acta Dermatovenerol Croat; 2014; 22(4):291-3. PubMed ID: 25580790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences with a long-term treatment of a massive gluteal acne inversa with infliximab in Crohn's disease.
    Goertz RS; Konturek PC; Naegel A; Janka R; Amann K; Maennlein G; Wein A; Hahn EG; Boxberger F
    Med Sci Monit; 2009 Jan; 15(1):CS14-8. PubMed ID: 19114971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
    Blanco R; Martínez-Taboada VM; Villa I; González-Vela MC; Fernández-Llaca H; Agudo M; González-López MA
    Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QUIZ HQ 40. Perineal abscesses and fistulas--always a mark of Crohn's disease?
    Gheorghe C; Cotruta B; Trifu V; Grasu M; Gheorghe L
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):307-8, 342. PubMed ID: 17944061
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
    Arenbergerova M; Gkalpakiotis S; Arenberger P
    Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of adalimumab in severe fistulising Crohn's disease].
    Bang UC; Nielsen AM
    Ugeskr Laeger; 2008 Jun; 170(25):2256. PubMed ID: 18565318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.
    Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S
    Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of recalcitrant hidradenitis suppurativa with ustekinumab.
    Sharon VR; Garcia MS; Bagheri S; Goodarzi H; Yang C; Ono Y; Maverakis E
    Acta Derm Venereol; 2012 May; 92(3):320-1. PubMed ID: 22101775
    [No Abstract]   [Full Text] [Related]  

  • 20. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab.
    Montes-Romero JA; Callejas-Rubio JL; Sánchez-Cano D; González-Martínez FJ; Navas-Parejo A; Ortego-Centeno N
    Eur J Intern Med; 2008 Oct; 19(6):e32-3. PubMed ID: 18848164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.